Doane College, NE's Series 2013 Bonds Assigned 'A' Rating Jan 13

  • ID: 2386885
  • January 2013
  • Standard & Poors
1 of 3


  • Crete
  • Doane Coll
  • Saline Cnty
  • MORE

CHICAGO (Standard & Poor's) Jan. 25, 2013--Standard & Poor's Ratings Services assigned its 'A' long-term rating to Crete, Neb.'s $7.09 million series 2013 fixed-rate revenue bonds issued on behalf of Doane College. In addition, Standard & Poor's assigned its 'A' long-term rating to Saline County, Neb.'s $9.85 million series 2013A and $8.45 million series 2013B fixed-rate revenue bonds also issued for Doane College. The outlook is stable. "The 'A' rating reflects our view of Doane's strong financial resource ratios, light debt levels, and growing enrollment trends in its traditional four-year program along with positive net tuition revenue trends," said Standard & Poor's credit analyst Suzie Desai. The total series 2013 revenue bond issuance will be approximately $25 million in fixed-rate...

Companies mentioned in this report are:
- Doane Coll
- Crete
- Saline Cnty

Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Doane Coll
- Crete
- Saline Cnty

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.